Psoriasis Knowledge Centre relaunches on Medthority.com
The Psoriasis Knowledge Centre provides a comprehensive guide to the condition, delving into established topical, systemic and biologic treatments available for psoriasis as well as novel treatments, such as TNFα and interleukin antagonists.
You can delve into topics which uncover Disease Awareness, enabling you to learn about the trigger factors, comorbidities, the burden of psoriasis and the role of cytokines.
Read more about guidelines and management information on how to measure the response to treatment.
Discover how recent advances mean there are a number of new treatments available which target different signalling pathways including both TNFα inhibitors and interleukin-based therapies.
When it comes to psoriasis, a knowledgeable healthcare professional is highly valued by patients (Pariser et al., 2016). With this in mind, we created The Psoriasis Academy, an online hub featuring succinct and easily accessible information for all healthcare professionals who want to know more about psoriasis and keep up to date with the latest developments.
Related news and insights
Arcutis Biotherapeutics, Inc. announced it has submitted a new drug application (NDA) to the FDA for roflumilast cream for the treatment of mild-to-severe plaque psoriasis.
Arcutis Biotherapeutics, Inc. announced it had enrolled the first patient in its single Phase III clinical trial evaluating topical roflumilast foam (ARQ-154) as a potential treatment for scalp and body psoriasis.